Structures by: Loughlin W. A.
Total: 21
C14H18O2S
C14H18O2S
Journal of the Chemical Society, Perkin Transactions 2 (2002) 2 296
a=11.296(3)Å b=22.296(3)Å c=10.547(4)Å
α=90° β=90° γ=90°
C14H18O2S
C14H18O2S
Journal of the Chemical Society, Perkin Transactions 2 (2002) 2 296
a=12.719(6)Å b=19.14(1)Å c=11.106(7)Å
α=90° β=102.55(5)° γ=90°
C14H18O2S
C14H18O2S
Journal of the Chemical Society, Perkin Transactions 2 (2002) 2 296
a=12.774(2)Å b=9.135(2)Å c=11.388(2)Å
α=90° β=104.79(1)° γ=90°
2-(3-Benzylamino-2-oxo-1,2-dihydropyridin-1-yl)-<i>N</i>-(3,4-dichlorobenzyl)acetamide
C21H19Cl2N3O2
Acta crystallographica. Section C, Crystal structure communications (2013) 69, Pt 11 1408-1410
a=18.9215(8)Å b=11.5507(5)Å c=8.9392(3)Å
α=90° β=93.874(3)° γ=90°
Ethyl (3-nitro-2-oxo-1,2-dihydropyridin-1-yl)acetate
C9H10N2O5
Acta Crystallographica Section E (2006) 62, 7 o2714-o2716
a=20.175(4)Å b=8.333(3)Å c=12.729(4)Å
α=90° β=100.49(2)° γ=90°
2-[2-(Phenylsulfonyl)ethyl]cyclopentanone
C13H16O3S
Acta Crystallographica Section E (2002) 58, 12 o1418-o1420
a=11.986(2)Å b=12.387(6)Å c=9.2183(13)Å
α=90° β=110.293(14)° γ=90°
C16H22O3S
C16H22O3S
Acta Crystallographica Section E (2002) 58, 11 o1280-o1282
a=12.641(3)Å b=20.240(5)Å c=6.051(2)Å
α=90° β=90° γ=90°
(1RS,2RS,6SR,8SR)-2-Methyl-8-(phenylsulfonyl)bicyclo[4.2.0]octan-1-ol
C15H20O3S
Acta Crystallographica Section E (2004) 60, 7 o1151-o1153
a=12.328(6)Å b=10.362(4)Å c=12.149(2)Å
α=90° β=99.60(3)° γ=90°
(1RS,2SR,6SR,8SR)-2,6-Dimethyl-8-(phenylsulfonyl)bicyclo[4.2.0]octan-1-ol
C16H22O3S
Acta Crystallographica Section E (2004) 60, 7 o1154-o1156
a=11.340(3)Å b=18.026(6)Å c=7.8442(16)Å
α=90° β=106.788(18)° γ=90°
3-(Z)-isobutylidene-1-acetylpiperazine-2,5-dione
C10H14N2O3
Acta Crystallographica Section E (2003) 59, 11 o1807-o1809
a=10.7310(18)Å b=10.827(3)Å c=9.7916(14)Å
α=95.607(17)° β=94.680(13)° γ=76.484(17)°
[(phenylmethyl)sulphonyl]methanol
C8H10O3S
Acta Crystallographica Section E (2002) 58, 2 o137-o138
a=22.758(11)Å b=7.160(7)Å c=5.422(2)Å
α=90° β=91.88(3)° γ=90°
1-phenyl-2-phenylsulfinyl-cyclobutan-1-ol
C16H16O2S
Acta Crystallographica Section E (2002) 58, 3 o303-o305
a=10.439(2)Å b=17.361(3)Å c=15.555(2)Å
α=90° β=92.740(10)° γ=90°
3,6-(Z,Z)-Bis[(3,4,5-trimethyoxyphenyl)methylene]piperazine-2,5-dione
C24H26N2O8
Acta Crystallographica Section E (2005) 61, 5 o1443-o1445
a=35.204(3)Å b=5.282(6)Å c=12.738(4)Å
α=90° β=97.503(15)° γ=90°
Spiro[1,3-dioxolane-2,4'-[8]phenylsulfonylbicyclo[4.2.0]octan[1]ol]
C16H20O5S
Acta Crystallographica Section E (2003) 59, 6 o789-o791
a=5.736(3)Å b=11.468(5)Å c=12.095(4)Å
α=81.1(6)° β=98.83(3)° γ=98.03(3)°
(+-)1-Hydroxy-6,6-dimethyl-1H,6H-naphtho[1,2-c]furan-3,9-trione.
C14H12O4
Acta Crystallographica Section E (2006) 62, 4 o1440-o1442
a=10.4825(13)Å b=7.0735(17)Å c=16.081(3)Å
α=90° β=90.556(12)° γ=90°
<i>tert</i>-Butyl 2-(3-acetylamino-2-oxo-1,2-dihydro-1-pyridyl)acetate
C13H18N2O4
Acta Crystallographica Section E (2008) 64, 12 o2492-o2493
a=13.9417(15)Å b=5.5850(10)Å c=17.861(2)Å
α=90° β=97.039(9)° γ=90°
1-(ethoxycarbonyl)-7-bromo-5,6,7,8-tetrahydro-5,6-dimethyl-8-oxonapthelene -2-carboxylic acid
C16H17BrO5
Journal of Organic Chemistry (2008) 73, 3435-3440
a=15.915(6)Å b=19.022(10)Å c=10.736(5)Å
α=90° β=90° γ=90°
1,3,6,9-tetrahydro-6,6-dimethyl-3,9-dioxonaptho[2,1-c]furan-1-yl acetate
C16H14O5
Journal of Organic Chemistry (2008) 73, 3435-3440
a=16.557(2)Å b=11.614(3)Å c=14.704(2)Å
α=90° β=97.413(12)° γ=90°
Hypodermin B
C14H14O4
Journal of Organic Chemistry (2006) 71, 2384-2388
a=15.937(5)Å b=7.227(3)Å c=10.649(3)Å
α=90° β=91.00(2)° γ=90°
C30H40O4S2
C30H40O4S2
Journal of Organic Chemistry (2004) 69, 5690-5698
a=9.99(1)Å b=11.47(1)Å c=13.073(5)Å
α=90° β=108.77(4)° γ=90°
C15H20O2S
C15H20O2S
Journal of Organic Chemistry (2004) 69, 5690-5698
a=9.237(2)Å b=25.003(6)Å c=6.240(2)Å
α=90° β=90° γ=90°